Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium

PURPOSE: In 75% of ovarian cancer patients the tumor mass is completely eradicated by established surgical and cytotoxic treatment; however, the majority of the tumors recur within 24 months. Here we investigated the role of circulating tumor cells (CTCs) indicating occult tumor load, which remains...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Obermayr, Eva, Bednarz-Knoll, Natalia, Orsetti, Beatrice, Weier, Heinz-Ulrich, Lambrechts, Sandrina, Castillo-Tong, Dan Cacsire, Reinthaller, Alexander, Braicu, Elena Ioana, Mahner, Sven, Sehouli, Jalid, Vergote, Ignace, Theillet, Charles, Zeillinger, Robert, Brandt, Burkhard
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739744/
https://ncbi.nlm.nih.gov/pubmed/29290959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22468
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados